Adalta Limited MC ~14$m SOI 525m plus incentives SP $0.028
AdAlta Limited is a clinical stage drug development company headquartered in Melbourne, Australia. The Company is using its proprietary i-body technology platform to solve drug targeting problems and generate a new class of single domain antibody protein therapeutics with the potential to treat some of challenging medical conditions.
Daily chart 3 spike highs and sold off into all of them. Lots of sellers getting out on spikes Register getting flushed - deadwood exit 50 EMA about to break through 200EMA and the first time in all the duration of time when 3 spikes occurred that it actually looks like crossing. 50 EMA is actually rising this time Price has formed basing pattern Ichimokou turning green again
Topping up
From Preso released today re Cellular Immunotherapy leg of their journey and MOU with SYNBV
